2m 2m 2m 2m 2m 2m 2m
COGNITION THERAP (CGTX)
NASDAQ
$1.00+$0.004 (+0.41%)
Price as of Aug 21, 2026 7:30 PM EDT- $94.7MMarket Cap
- -64.56%1-Year Change
- BiotechnologyIndustry
COGNITION THERAP (CGTX)
$1.00+$0.004 (+0.41%)
CGTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.00 | ||
Change | +$0.04 (+4.10%) | ||
Open | $0.97 | ||
High | $1.01 | ||
Low | $0.97 | ||
Previous Close | $0.96 | ||
Volume | 308,326 | ||
30-Day Average Volume | 536,392 | ||
1-Week Change | -1.40% | ||
1-Month Change | -0.41% | ||
1-Year Change | -64.56% | ||
3-Year Change | -32.25% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 95.1M | ||
Total Assets | $38.9M | ||
Market Cap | $94.7M | ||
Enterprise Value | $60.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.9M | ||
Free Cash Flow | -$3.1M | ||
EBIT | -$3.9M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $32.8M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -25 | ||
PEG | -1 | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue